Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
11.2 Capital
AddedFeb 13, 2024
UpdatedJun 28, 2026
11.2 Capital

11.2 Capital

Operating

11.2 Capital: A San Francisco-based venture capital fund, investing in and nurturing global tech startups.

Location
San Francisco, CA, US
Founded
2013
Firm
Compare
Portfolio
Employees
Website

Investments

Kolena
Kolena

Total Raised

$21.5M

Rounds

2

Series A$15MSeptember 2023
Noetik
Noetik

Total Raised

$14M

Rounds

1

Seed$14MSeptember 2023
Orbital Sidekick
Orbital Sidekick

Total Raised

$46.8M

Rounds

6

Series Unknown$10MJanuary 2023
Series A$16MJanuary 2021
Coalesce Automation
Coalesce Automation

Total Raised

$31.9M

Rounds

2

Series A$26MSeptember 2022
Seed$5.9MJanuary 2022
Odys Aviation
Odys Aviation
Seed

Total Raised

$15.9M

Rounds

4

Seed$12.4MFebruary 2022
Permiso Security
Permiso Security

Total Raised

$10M

Rounds

1

Seed$10MJanuary 2022
Mantle
Mantle

Total Raised

$38M

Rounds

3

Series B$25MSeptember 2021
Series Unknown$13MFebruary 2021
StrikeReady
StrikeReady

Total Raised

$3.6M

Rounds

2

Seed$3.6MApril 2021
Sardine
Sardine

Total Raised

$75.6M

Rounds

5

Seed$4.6MMarch 2021
Hinge Health
Hinge Health
Secondary Market

Total Raised

$1B

Rounds

10

Series D$300MJanuary 2021
Series C$90MFebruary 2020
Series A$8.3MJuly 2017
Seed$1.3MJune 2016
JupiterOne
JupiterOne

Total Raised

$119M

Rounds

3

Series A$19MSeptember 2020
Auransa
Auransa

Total Raised

$18.5M

Rounds

2

Series A$15.7MAugust 2020
Anyscale
Anyscale

Total Raised

$259M

Rounds

4

Series A$20MDecember 2019
Notable Labs
Notable Labs
Public

Total Raised

$55M

Rounds

9

Series B$40MJuly 2019
Covariant
Covariant

Total Raised

$222M

Rounds

5

Seed$7MNovember 2017
Molecular Assemblies
Molecular Assemblies

Total Raised

$87.2M

Rounds

9

Seed$2.3MDecember 2016
Lucira Health
Lucira Health
Public

Total Raised

$147.3M

Rounds

11

Series A$13.1MOctober 2015
Ginkgo Bioworks
Ginkgo Bioworks
Public

Total Raised

$1.6B

Rounds

17

Series B$53.3MJuly 2015
Placenote
Placenote
Seed

Total Raised

$1.5M

Rounds

6

Seed$1MMarch 2015